Effects of antenatal melatonin therapy on lung structure in growth-restricted newborn lambs

Graeme R Polglase1,2, Jade Barbuto1, Beth J Allison1

  • 1The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.

Insights

Fetal growth restriction (FGR) impairs lung development by disrupting alveolar septation. Antioxidant melatonin did not alter these structural changes, suggesting oxidative stress isn't the primary cause in FGR lambs.

Area of Science:

  • Perinatal Medicine
  • Developmental Biology
  • Respiratory Physiology

Background:

  • Suboptimal placental function in fetal growth restriction (FGR) leads to infant pathologies, including respiratory dysfunction.
  • Oxidative stress is implicated in FGR-related adverse lung development and poor long-term lung function.

Purpose of the Study:

  • To investigate the contribution of oxidative stress to altered lung development in FGR.
  • To evaluate the effects of melatonin, an antioxidant, on lung structure in FGR lambs.

Main Methods:

  • Surgically induced FGR in 13 fetal sheep via umbilical artery ligation.
  • Administered maternal intravenous melatonin to seven ewes from surgery until birth.
  • Assessed lung structure and injury histologically 24 hours after birth in term lambs.

Main Results:

  • FGR lambs exhibited reduced secondary septal crest density and altered elastin deposition.
  • Melatonin administration prevented chronic hypoxia in FGR fetuses.
  • Melatonin did not alter the FGR-induced structural changes in the developing lung.

Conclusions:

  • Chronic FGR disrupts alveolar septation development.
  • Oxidative stress is unlikely to be the primary mechanism driving altered lung structure in FGR.
  • Melatonin did not affect FGR-induced airway development but had no adverse effects.

Related Concept Videos